Post-marketing Surveillance of Ventilat® Metered Dose Inhaler in Chronic Obstructive Bronchitis

Boehringer Ingelheim

Status: Completed

Conditions: Pulmonary Disease, Chronic Obstructive

Treatments: Drug: Ventilat® - metered dose inhaler

Study type: Observational

Funder types: Industry

Identifiers

NCT02233920

54.564

Details and patient eligibility

About

Study to obtain further information on the tolerability and efficacy of Ventilat® metered-dose inhaler in the treatment of Chronic Obstructive bronchitis under conditions of daily practice

Enrollment: 716 patients

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Primarily Patients of both genders older than 40 years, who suffer from Chronic Obstructive bronchitis
• Only patients who have not been treated with an anticholinergic within the last year are to be considered for inclusion

Exclusion criteria

•Contraindications listed in the Instructions for Use/Summary of Product Characteristics for Ventilat® metered dose inhaler

Trial design

716 participants in 1 patient group

Chronic obstructive bronchitis patients

Treatment:

Drug: Ventilat® - metered dose inhaler